Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My best guess is they are trying to get the most bang for the buck.
1) I think the big thing they are waiting for is for most insurance companies to update there coverage mid year review. I know many of them update monthly or quarterly but I think AMRN is going for the most insurance coverage possible before DTC.
2) Also all Sales reps hired and trained and calling upon docs.
3) Plus it buys them time for BO or EU talks if they are in progress.
Well that makes sense as that is exactly what I saw for a price difference. Thank you for letting me know that is great.
OK just checked my records. In January I paid 214 and just yesterday I paid 174. Hope this helps.
Yes I picked up mine yesterday at Walmart and noticed the price was about 25 to 55 dollars cheaper. I am using the coupon with a high deductible BCBS company insurance plan. I will check when I get home for the exact amount less that I was charged. I was expecting the price to be 2?? but it ended up being 174. This is for one month.
All your views are short term concerns. I am looking at this as a longer term solution/retirement. If you believe any of the concerns you listed to be a real threat then why are you still invested here. Because of FOMO and the true potential of this company therefore you believe it safer/better to stay then to go. Also there are risks in every investment out there not a one that I can see that is risk free. Is this investment riskier then others sure but you can't match the potential here in an ETF.
In the mean time you sweat the small stuff the short term action on the stock where you believe my money has to make money every minute it is invested. Me not so much as I am happy all my shares are in the black and in the long run I should be set for life.
So all we are simply talking about here is my and your definition of simply safe are just different. Well if it helps you can call it comfortably numb instead.
Well if you believe that then why are you still invested here take your money and go invest in your so called greener pastures. I am good here.
Well since I have been invested in AMRN for the last 10 years and no such events you worry about have happened in the last 10 years. I would say I probably am right.
As a matter of fact the only thing that has happened in the last ten years is I have become richer, sleep better, and worry less.
Sorry about the stereotyping I should have stated 90 percent of the BOB's will fit my scenario. Glad to see you are thinking about your future and safer investments that will help you worry less.
Good luck to you,
Please add me to that list.
Another important thing to note is another great quote by JL to the BOB's.
Even if you did get a buyout it only enables you to lose your money on another investment faster. Remember slow nickels beat fast dimes.
So if these BOB's can't even see through the newbie's posts how are they ever going to be able to successfully invest outside of AMRN.
Basic message sit down shut up and enjoy the ride you are making money in a simply safe investment, and be sure to thank JL for his spot on efforts on educating you.
Thank you JL,
I agree and I am just not sure if JT is subtly telling us that is how long it will take for the company to reach that point.
Which would make the stock price languish a bit kind of like it is now. Also lending a bit more credence to GIA as well.
I agree with 3 and 5 if you look at my earlier post. Post 238958.
I have been thinking about this for a while on why JT keeps stating 6 months until DTC ads. The only plausible scenario I can come up with is he wants to be firing on all cylinders when DTC hits the air waves.
1) sales force and support up and trained and educating docs full swing.
2) most if not all insurance formularies at lower tiers.
Hence getting the most bang for his DTC buck.
Love.
New bottle of Vascepa on Ebay for $95. FYI
Well look at the pot calling the kettle black. What a waste of MB space.
Since we are going to close above your proclaimed price range of 14.75 to 15.25. Can you let me know what major news came out that got us above this range I must have missed it?
Don't forget boys and girls max pain for today is 15.50 so I would not expect it to close much above that.
I agree completely with this assessment. I wanted to thank you and HDGabor for straightening me out on understanding Evaporate and sorry for the what the heck are you talking about post as I misunderstood the interim and end date determinations.
I agree with you and posted the same.
clinicaltrials.gov/ct2/show/NCT02926027
What are you talking about this is not an interum stop it is the completion of the study with final results, but yes I assume it must be positive if it is on the late breaking list.
clinicaltrials.gov/ct2/show/NCT02926027
Abstract:
Authors:
T Konishi1 , 1Hokkaido University - Sapporo - Japan ,
Citation:
Background: The relationship between eicosapentaenoic acid (EPA) therapy and coronary plaque stability assessed by optical frequency domain imaging (OFDI) has not been thoroughly described.
Hypothesis: EPA therapy is associated with decreased plaque instability in patients undergoing percutaneous coronary intervention (PCI) using OFDI.
Methods: Data on coronary artery plaques from 121 patients presenting with acute coronary syndrome or stable angina who consecutively underwent PCI between October 2015 and July 2018 were retrospectively analyzed. Of these patients, 109 were untreated (no-EPA group), whereas 12 were treated with EPA (EPA group). Each plaque’s morphological characteristics were analyzed using OFDI.
Results: We used 1:4 propensity score matching for patients who received or did not receive EPA therapy before PCI. Baseline characteristics were balanced between both groups (age, sex, body mass index, diabetes mellitus, hypertension, dyslipidemia, chronic kidney disease, smoking, previous PCI or coronary artery bypass grafting, previous myocardial infarction, prior statin use, acute coronary syndrome, hemoglobin A1c level, low-density lipoprotein cholesterol concentration, triglyceride concentration, and high-density lipoprotein cholesterol concentration). The EPA group had significantly lower mean lipid index (818±806 vs. 1,574±891) and macrophage grade (13.5±5.9 vs. 19.3±7.4) but higher mean minimum fibrous cap thickness (109.2±55.7 vs. 81.6±36.4 µm) than the no-EPA group (P=0.010, 0.019, and 0.040, respectively). Multiple logistic regression analyses showed that prior EPA use was independently associated with lower lipid index and macrophage grade (P=0.043 and 0.024, respectively).
Conclusion: This OFDI analysis suggests that EPA therapy is associated with decreased plaque instability in patients undergoing PCI.
//esc365.escardio.org/Congress/ESC-CONGRESS-2019/Poster-Session-6-Lipid-management-and-outcome/198769-eicosapentaenoic-acid-therapy-is-associated-with-decreased-coronary-plaque-instability-assessed-using-optical-frequency-domain-imaging
What do we think of this gem coming up next week.
Any one with jacc subscription that can give a synopsis of this would be much appreciated.Sorry if already posted.
http://heartfailure.onlinejacc.org/content/early/2019/07/03/j.jchf.2019.03.008?download=true
Cool then you and me are in full agreement. I should have gone back in the posting chain to see that my bad.
One I see it as your second statement supersedes your first one because more experts than what they can put on the panel have already chimed in and with more to come the FDA already has all the cover they need and with no safety issues I vote no ADCOM.
One more thing to add if it is so much better at bio availability then AZN should have ended the strength study with stellar results not extended it a year. I agree with your assessment.
In case this helps anybody on the board or a family member. There is a bottle of Vascepa on Ebay for $99.00. That seems to be the going rate for the last so many.
Hope this helps,
Probably not going to bump the reps until better insurance coverage. That means after label change and formulary updates. Between label change and formulary updates there will be plenty of time to get reps trained. How many more reps over 400 do they need I don't know I am betting they will be able to gauge by how effective the current reps are until then.
To add to JL's point this also give them time to see how effective Bhatt and education of medical field correlates to scripts, which will also help them figure out just how many more they need.
I am in the same boat you are very long the stock and would be ecstatic to see all of the mentioned organizations put V down as SOC. Thank you for sharing your knowledge on the topic.
Is it possible SOC wording was suggested by the ACC reviewers leading into what they will do with their guidelines, and the ADA is just following. Sorry for the duplicate response after I posted I see others replied similar to my post.
A buddy of mine just texted me he read on some other boards there was an offer of 79 turned down by Amarin. LOL
I just laughed and told him don't be a BOB and he and his dad should buy more and hold cause it will be a lot higher than that in the long run.
Thanks for your commentary and with you all the way.
See post# 183533. Again great DD on letting us know this was coming weeks ago.
Up next is ACC and AHA updates in due time. Great news and thank you for posting.
I would also like to say LOL!!!! To all who jumped all over ilovetech when he told us this was coming weeks ago. Proves he is a stand up guy with good info which I already knew. Great job.
Sounds to me as if Davidson is interested in working for Amarin in the future.
Agreed and we know they are open to an EU partner. With a partnership usually comes a cash infusion which further dispels that Fake news.
Hmmmm to me it looks like a 6 month cup and handle coming into to play so I am going to play devil's advocate here.
What I can't get a handle on(pun intended) is when we break the 22/23 area what will be the catalyst that will gap us into the 30's.
ITC - nah
Scripts - will help the handle complete but not the catalyst.
SNDA submission - nah
BO - nah
FDA accel review - a little early for that but possible
Evaporate end early - not likely
Strength end early - not likely
Best I can figure is a stellar Partner for Europe with submission to EU soon after SNDA.
Yeah, Yeah a few months back they said the same thing an all cash deal with PFE and that negotiations completed on a Wed. and buyout was imminent. Low and behold here we are today and nothing has happened.
I say no buyout this soon and most likely never. I am in the same boat about the ITC case most likely never to be decided.
I am glad I am not the only one that can see right the this poster. I also love how he post what a great swing trader and has over 40 years investing experience. Give me a break if you look you can see amateur softy easily.
Or he might Shartma.
Cardiologymd,
Thank you so much for your response. I really appreciate it and I love medical advice that encourages drinking red wine even better (just kidding) but I guess I will have to join the wife with red wine instead of a beer heck yeah I can do that. Plus I will get workout routine up and going again.
No hypertension but am still going to keep working on dropping my total Cholesterol to below 160.
Thanks again and enjoy reading your posts.
Yesterday I received my best numbers yet from my blood work but I had some interesting talking points with the doctor that I would like the boards opinion on. First I want to thank many people on this board who got me to change the way I eat a year ago and I started on the 16 hour fasting everyday. I also from my own research added an egg a day to my diet. My weight went from 198 to 182.
Some background on me is I am a 54 year old male who has been pre-diabetic since I can remember checking it. Have been on Vascepa for over two years. I am a healthy eater for the most part. Usually I would exercise at least three times a week but I have been slipping this winter on that.
The starting numbers came from my old way of eating but being on Vascepa.
First the good:
My total Cholesterol went from 206 to 171 (yeah no statin)
Trigs from 127 to 90
A1C from 6.1 to 5.6 (which took me out of pre-diabetic range for the first time ever).
Everything else was good.
The not so good:
But my HDL-C went from 36 to 29 which was a bit alarming.
Doctor who is a general practitioner stated two interesting things of which I would like the boards opinion on:
Her opinion was that LDL-C was mostly hereditary and I could only affect it by 20% at most with my diet.
My HDL-C could no be affected by my diet but only affected by exercise.
Exactly correct and then I am sure you can figure out who the stool sample represents that you are perched upon. Hee Hee Hee Hee!!!!!!!!